Nuclear hormone receptor ligand binding domain

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/16 (2006.01) A01K 67/027 (2006.01) A61K 31/7088 (2006.01) A61K 38/17 (2006.01) A61K 39/395 (2006.01) C07K 14/705 (2006.01) C07K 14/72 (2006.01) C07K 16/28 (2006.01) C12Q 1/68 (2006.01) G01N 33/566 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2439192

This invention relates to a novel protein, termed LBDG3, herein identified as a Nuclear Hormone Receptor Ligand Binding Domain and to the use of this protein and nucleic acid sequence from the encoding genes in the diagnosis, prevention and treatment of disease.

La présente invention concerne une nouvelle protéine, appelée LBDG3 qui a été identifiée comme étant un domaine de liaison du ligand du récepteur hormonal nucléaire, ainsi que l'utilisation de cette protéine et de la séquence d'acides nucléiques issue des gènes codants pour effectuer le diagnostic, la prévention et le traitement de maladies.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Nuclear hormone receptor ligand binding domain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nuclear hormone receptor ligand binding domain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nuclear hormone receptor ligand binding domain will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1695848

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.